Komen to Reformulate Perfume After Unfavorable Allegations

Thursday, Oct 13, 2011  |  Updated 10:52 AM CDT
View Comments (
)
|
Email
|
Print
Komen to Tweak Perfume After Carcinogen Claims

PromiseMeFragrance.com

advertisement

A perfume endorsed by the Susan G. Komen for the Cure foundation has come under fire.

The "Promise Me" perfume is facing accusations that certain incredients may be dangerous carcinogens that could cause cancer.

A group called "Breast Cancer Action" sent the perfume to be tested at Analytical Sciences, a California chemical lab.

A report on the test revealed it contained galaxolide, a synthetic musk that has been shown to accumulate in the body of women whose perfumes contained it, according to DailyFinance.com. The report goes on to allege that the ingredient may be a contributing factor in the development of breast cancer.

The Dallas-based Komen group said the accusations made aren't true and that it had scientists and health teams review every ingredient in the perfume — none of which, it says, are linked to cancer in humans.

DailyFinance said the perfume will be reformulated without certain ingredients being criticized.

The perfume, which runs about $60 a bottle, was first released in 2001
 

Get the latest headlines sent to your inbox!
View Comments (
)
|
Email
|
Print
Leave Comments
What's New
Get NBCDFW on Mobile!
Get NBCDFW's free news and weather... Read more
Follow Us
Sign up to receive news and updates that matter to you.
Send Us Your Story Tips
Check Out